SGX Market Updates By SGX My Gateway

SGX Market Information

SGX My Gateway Market Updates

FTSE ST Fledgling Index’s Five Best-Performing New Constituents Avg 21% YTD Gain

20 March 2018

In FTSE’s latest semi-annual review of its ST Index series, 20 component stocks were added to the FTSE ST Fledgling Index, while 8 were removed. After changes that took effect on 19 March, the Fledgling Index now comprises 219 stocks, with a combined market capitalisation of S$25.7 billion. In the 2018 year-to-date, the five best-performing inclusions to the FTSE ST Fledgling Index were: APAC Realty (36.0%), Blumont Group (33.3%), Cityneon (14.4%), Sarine Technologies (13.0%) and Debao Property (8.7%).

Ascendas-Singbridge Building Strengths & Deepening its Presence

SGX My Gateway

08 March 2018

Jointly owned by Temasek Holdings and JTC Corporation, Ascendas-Singbridge undertakes urbanisation development projects and manages 3 SGX-listed trusts include Ascendas REIT, Ascendas India Trust and Ascendas Hospitality Trust, and a series of private real estate funds. Total AUM was S$22.4 billion as of March 2017. The three trusts respectively represent REITs, Business Trusts and the Stapled Trusts, which maintain different ownership and management structures were listed on SGX between November 2002 and July 2012, have averaged 8.8% annualised total returns from their respective IPO dates.

Mapletree Delivered Growth & Value to its REIT Unitholders

SGX My Gateway

05 March 2018

Mapletree Investments was established in December 2000 to hold non-port properties transferred from PSA Corporation to Temasek Holdings. Between 2005 and 2013, Mapletree Logistics Trust (“MLT”), Mapletree Industrial Trust (“MIT”), Mapletree Commercial Trust (“MCT”) and Mapletree Greater China Commercial Trust (“MGCCT”) listed on SGX. Combined market cap of these REITs grew 2.6x to present. The four Mapletree REITS have averaged 14.5% distribution-inclusive returns from IPO date to present & currently maintain an average 6.0% distribution yield. MIT has been the strongest performer of the four REITs, with 18.2% average annualised total returns.

Long Term Returns of Temasek’s Major SGX-listed Investments

SGX My Gateway

27 February 2018

Temasek is a 100% Singapore Government-owned Investment Company, established in 1974 with the purpose of separating Singapore Government’s policy making role from the management of its commercial assets. Temasek includes SGX-listed stocks DBS Group Holdings, Singtel, Keppel Corp, Sembcorp Industries, ST Engineering, Singapore Airlines, CapitaLand, Olam International and SATS as major portfolio investments. Of the 9 stocks, 6 have been listed for the past 20 years, averaging annualised total returns of 8.1%. Three stocks, Sembcorp Industries, SATS and Olam International listed within the 20 years, averaging 10.8% annualised total returns from respective debuts.

Recent Highlights of Singapore-Focused Real Estate Stocks

SGX My Gateway

21 February 2018

The 25 largest capitalised Real Estate stocks that reported more than 80% of their revenue to Singapore based on Annual Reports, maintain an average market cap of S$3.0 billion, ranging from S$7.5 billion for Ascendas REIT to S$718 million for Hong Fok Corp. After strong performances in 2017, when all 25 stocks gained & averaged a 28.5% total return, 18 of the 25 stocks declined over the first seven weeks of 2018, with average YTD price declines at 2.7%. The 7 of the 25 stocks that generated price gains in the YTD include ESR-REIT, OUE, Oxley Holdings, United Industrial Corp, AIMS AMP Capital Industrial, Far East Hospitality Trust and OUE Hospitality Trust.

Highlights of Singapore’s Best-Yielding Billionaire Plays

SGX My Gateway

14 February 2018

SGX lists 36 stocks with market cap above S$1 billion and dividend yields above 4%. Of the 36 stocks, 29 are trusts (REITS, Stapled Trusts or Business Trusts), while seven are companies. This includes 8 STI stocks. The five highest-yielding companies stocks include Hi-P International, M1 and STI constituents StarHub, ST Engineering and ComfortDelgro. The five highest-yielding REITs and business trusts include Lippo Malls Indonesia Retail Trust (8.8%), Hutchison Port Holdings Trust, Frasers Commercial Trust, Ascendas REIT, and OUE Commercial REIT/ Keppel Infrastructure Trust.

Recent Highs and Lows of STI Stocks

SGX My Gateway

07 February 2018

Following suit on the Monday and Tuesday sessions the regional MSCI AC Asia Pacific Index declined 4.9% while the STI declined 3.5%. One third of the STI stocks traded at 3-month lows yesterday. The remaining 20 STI stocks are on average 7.0% off their 3-month highs, with a majority of those highs made in Jan 2018. The 20 stocks include SATS, Singapore Airlines and Thai Beverage which on average declined the least, at -1.1%, over the two sessions of 5 Feb to 6 Feb.

SGX January 2018 Share Buyback Value at S$54 million, up 26% from December 2017

SGX My Gateway

02 February 2018

In the month of January 2018, there were 20.1 million shares repurchased by 16 companies, with a total consideration of S$53.5 million. The five stocks with the largest buyback consideration value last month were Keppel Corp, OCBC, Silverlake Axis, Singapore Post and Perennial Real Estate, which made up as much as 98% of the S$53.5 million in total consideration.

LY Corporation – A Play on US Home Sales Market

SGX My Gateway

31 January 2018

LY Corporation, one of Malaysia’s leading manufacturers and exporters of wooden bedroom furniture, made its trading debut on the Catalist today, being the first SGX IPO of 2018. SGX lists three active stocks in the furniture-related businesses with a combined market capitalisation of about S$240 million. They are Courts Asia, Koda Ltd, and Lorenzo International.

Singapore’s Fast-Expanding MedTech Sector

SGX My Gateway

25 January 2018

Asia’s MedTech (Medical Technology) Sector is expected to become the second largest globally by 2020 (with CAGR of 8%). Singapore is becoming a regional MedTech hub as supportive government policies and the manufacturing sector contribute positively. SGX lists four stocks with MedTech businesses (Clearbridge Health, Techcomp Holdings, Vicplas International and QT Vascular) with a combined market capitalisation of S$413 million. A handful of SGX IT companies have also diversified some of their businesses into MedTech, including Venture Corp.

These articles are provided by SGX My Gateway.

SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.

Stock / REIT Search

DBS Share Price , UOB Share Price, SingTel Share Price, OCBC Share Price
Prime US REIT IPO